209 related articles for article (PubMed ID: 23936217)
1. Aberrant expression and secretion of heat shock protein 90 in patients with bullous pemphigoid.
Tukaj S; Kleszczyński K; Vafia K; Groth S; Meyersburg D; Trzonkowski P; Ludwig RJ; Zillikens D; Schmidt E; Fischer TW; Kasperkiewicz M
PLoS One; 2013; 8(7):e70496. PubMed ID: 23936217
[TBL] [Abstract][Full Text] [Related]
2. Hsp90 blockade modulates bullous pemphigoid IgG-induced IL-8 production by keratinocytes.
Tukaj S; Grüner D; Zillikens D; Kasperkiewicz M
Cell Stress Chaperones; 2014 Nov; 19(6):887-94. PubMed ID: 24796797
[TBL] [Abstract][Full Text] [Related]
3. Correlation of Serum Levels of IgE Autoantibodies Against BP180 With Bullous Pemphigoid Disease Activity.
van Beek N; Lüttmann N; Huebner F; Recke A; Karl I; Schulze FS; Zillikens D; Schmidt E
JAMA Dermatol; 2017 Jan; 153(1):30-38. PubMed ID: 27829102
[TBL] [Abstract][Full Text] [Related]
4. Normal human skin is superior to monkey oesophagus substrate for detection of circulating BP180-NC16A-specific IgG antibodies in bullous pemphigoid.
Emtenani S; Yuan H; Lin C; Pan M; Hundt JE; Schmidt E; Komorowski L; Stanley JR; Hammers CM
Br J Dermatol; 2019 May; 180(5):1099-1106. PubMed ID: 30315657
[TBL] [Abstract][Full Text] [Related]
5. Preferential Reactivity of Dipeptidyl Peptidase-IV Inhibitor-Associated Bullous Pemphigoid Autoantibodies to the Processed Extracellular Domains of BP180.
Mai Y; Nishie W; Izumi K; Shimizu H
Front Immunol; 2019; 10():1224. PubMed ID: 31191560
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies Against the Immunodominant Bullous Pemphigoid Epitopes Are Rare in Patients With Dermatitis Herpetiformis and Coeliac Disease.
Nätynki A; Tuusa J; Hervonen K; Kaukinen K; Lindgren O; Huilaja L; Kokkonen N; Salmi T; Tasanen K
Front Immunol; 2020; 11():575805. PubMed ID: 33072118
[TBL] [Abstract][Full Text] [Related]
7. Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.
Di Zenzo G; Thoma-Uszynski S; Fontao L; Calabresi V; Hofmann SC; Hellmark T; Sebbag N; Pedicelli C; Sera F; Lacour JP; Wieslander J; Bruckner-Tuderman L; Borradori L; Zambruno G; Hertl M
Clin Immunol; 2008 Sep; 128(3):415-26. PubMed ID: 18571472
[TBL] [Abstract][Full Text] [Related]
8. IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid.
Zuo Y; Evangelista F; Culton D; Guilabert A; Lin L; Li N; Diaz L; Liu Z
J Autoimmun; 2016 Sep; 73():111-9. PubMed ID: 27377454
[TBL] [Abstract][Full Text] [Related]
9. Patients with bullous pemphigoid and linear IgA disease show a dual IgA and IgG autoimmune response to BP180.
Kromminga A; Scheckenbach C; Georgi M; Hagel C; Arndt R; Christophers E; Bröcker EB; Zillikens D
J Autoimmun; 2000 Nov; 15(3):293-300. PubMed ID: 11040070
[TBL] [Abstract][Full Text] [Related]
10. BPDAI and ABSIS correlate with serum anti-BP180 NC16A IgG but not with anti-BP230 IgG in patients with bullous pemphigoid.
Daneshpazhooh M; Ghiasi M; Lajevardi V; Nasiri N; Balighi K; Teimourpour A; Khosravi H; Saeidi V; Mahmoudi H; Chams-Davatchi C
Arch Dermatol Res; 2018 Apr; 310(3):255-259. PubMed ID: 29423547
[TBL] [Abstract][Full Text] [Related]
11. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
12. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
[TBL] [Abstract][Full Text] [Related]
13. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic sites on both the extracellular and the intracellular domains of the BP antigen 180.
Perriard J; Jaunin F; Favre B; Büdinger L; Hertl M; Saurat JH; Borradori L
J Invest Dermatol; 1999 Feb; 112(2):141-7. PubMed ID: 9989787
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of NLRP3 inflammasome components and interleukin-18 in patients with bullous pemphigoid.
Fang H; Shao S; Cao T; Lei J; Dang E; Zhang J; Wang G
J Dermatol Sci; 2016 Aug; 83(2):116-23. PubMed ID: 27174093
[TBL] [Abstract][Full Text] [Related]
15. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
Bing L; Xiping Z; Li L; Jun P; Yi-Xia W; Min Y; Qing L; Qiu-Ning S; Hong-Zhong J; Ya-Gang Z
Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084
[TBL] [Abstract][Full Text] [Related]
16. A highly sensitive and simple assay for the detection of circulating autoantibodies against full-length bullous pemphigoid antigen 180.
Schmidt E; Kromminga A; Mimietz S; Leinfelder U; Sitaru C; Bröcker EB; Zillikens D; Zimmermann U
J Autoimmun; 2002 Jun; 18(4):299-309. PubMed ID: 12144811
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180.
Zillikens D; Caux F; Mascaro JM; Wesselmann U; Schmidt E; Prost C; Callen JP; Bröcker EB; Diaz LA; Giudice GJ
J Invest Dermatol; 1999 Jul; 113(1):117-21. PubMed ID: 10417629
[TBL] [Abstract][Full Text] [Related]
18. A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180.
Shinojima Y; Ochiai T; Kawamura A; Arakawa H; Fukuda K; Hashimoto T
Clin Exp Dermatol; 2005 Sep; 30(5):503-5. PubMed ID: 16045678
[TBL] [Abstract][Full Text] [Related]
19. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to BP180 associated with bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes.
Schmidt E; Reimer S; Kruse N; Jainta S; Bröcker EB; Marinkovich MP; Giudice GJ; Zillikens D
J Invest Dermatol; 2000 Nov; 115(5):842-8. PubMed ID: 11069622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]